Long non-coding RNAs regulate drug resistance in cancer

116Citations
Citations of this article
112Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Chemoresistance, whether intrinsic or acquired, is a major obstacle in the treatment of cancer. The resistance of cancer cells to chemotherapeutic drugs can result from various mechanisms. Over the last decade, it has been reported that 1ong noncoding RNAs (lncRNAs) can mediate carcinogenesis and drug resistance/sensitivity in cancer cells. This article reviews, in detail, recent studies regarding the roles of lncRNAs in mediating drug resistance.

Cite

CITATION STYLE

APA

Liu, K., Gao, L., Ma, X., Huang, J. J., Chen, J., Zeng, L., … Chen, Z. S. (2020, March 12). Long non-coding RNAs regulate drug resistance in cancer. Molecular Cancer. BioMed Central Ltd. https://doi.org/10.1186/s12943-020-01162-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free